Drug Trial Radar · NCT07441408
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
2,380
Planned (sponsor's estimate)
Start
Dec 16, 2026
Primary completion
Nov 22, 2029
Study completion Mar 30, 2030
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).
Conditions
- Pulmonary Fibrosis
Interventions
BMS-986278Drug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: Up to Week 100
- Number of Participants With Serious Adverse Events (SAEs)Time frame: Up to Week 100
- Number of Participants With AEs leading to DiscontinuationTime frame: Up to Week 100
- Number of Participants With AEs leading to DeathsTime frame: Up to Week 100
- Number of Participants With Clinically Significant Laboraty AbnormalitiesTime frame: Up to Week 100
- Number of Participants With Clinically Significant Electocardiogram (ECG) AbnormalitiesTime frame: Up to Week 100
- Number of Participants With Clinically Significant Vital Sign AbnormalitiesTime frame: Up to Week 100
Locations
275 sites in 27 countries. Site status is shown where the registry gives one.
Local Institution - 0113
Birmingham, Alabama
Local Institution - 0111
Ocala, Florida
Local Institution - 0119
Philadelphia, Pennsylvania
Local Institution - 0010
Buenos Aires, Argentina
Local Institution - 0004
Buenos Aires, Argentina
Local Institution - 0016
CABA, Argentina
Local Institution - 0006
Mendoza, Argentina
Local Institution - 0008
Santa Fe, Argentina
Local Institution - 0003
Mar del Plata, B, Argentina
Local Institution - 0013
Florida, Vicente López, Buenos Aires, Argentina
Local Institution - 0014
Mar del Plata, Buenos Aires, Argentina
Local Institution - 0007
Quilmes, Buenos Aires, Argentina
Local Institution - 0009
San Juan Bautista, Buenos Aires, Argentina
Local Institution - 0001
Córdoba, Córdoba Province, Argentina
Local Institution - 0005
CABA, Distrito Federal, Argentina
Local Institution - 0011
Mendoza, M, Argentina
Local Institution - 0002
Godoy Cruz, Mendoza Province, Argentina
Local Institution - 0015
Rosario, S, Argentina
Local Institution - 0012
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution - 0286
Melbourne, Australia
Local Institution - 0284
Wentworthville, Australia
Local Institution - 0287
Camperdown, New South Wales, Australia
Local Institution - 0290
Chermside, Queensland, Australia
Local Institution - 0291
Greenslopes, Queensland, Australia
Local Institution - 0293
South Brisbane, Queensland, Australia
Local Institution - 0289
Adelaide, South Australia, Australia
Local Institution - 0288
Frankston, Victoria, Australia
Local Institution - 0285
Murdoch, Western Australia, Australia
Local Institution - 0292
Nedlands, Western Australia, Australia
Local Institution - 0248
Brussels, Belgium
Local Institution - 0251
Kortrijk, Belgium
Local Institution - 0250
Liège, Belgium
Local Institution - 0249
Yvoir, Namur, Belgium
Local Institution - 0252
Leuven, Vlaams-Brabant, Belgium
Local Institution - 0193
Rio de Janeiro, Brazil
Local Institution - 0025
Santo André, Brazil
Local Institution - 0066
São Paulo, Brazil
Local Institution - 0192
São Paulo, Brazil
Local Institution - 0086
Belo Horizonte, Minas Gerais, Brazil
Local Institution - 0031
Belo Horizonte, Minas Gerais, Brazil
Showing 40 of 275 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.